A Study of Patients With Major Depressive Disorder and Residual Apathy
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide a comparison of the apathy, depression, and
functional outcomes associated with switching to duloxetine or escitalopram in patients who
have previously responded to treatment with a selective serotonin reuptake inhibitor (SSRI)
for major depressive disorder and who have residual apathy in the absence of depressed mood.